Clinical Study on Laparoscopic Resection of Splenic Artery Aneurysm With Preservation of Spleen

Condition(s) studied

Investigational drug(s) / intervention(s)

laparoscopic resection of splenic artery aneurysm with preservation of spleen: The laparoscopic resection of splenic artery aneurysm with preservation of spleen is performed by the same surgical team.

Study summary

In this study, researchers examined the changes in related indicators such as immune function, splenic vein,proper hepatic artery, and portal venous hemodynamics following laparoscopic resection of a splenic artery aneurysm. We determined the changes in these patient-related indicators after surgical treatment and whether these changes could improve patient outcomes.

Eligibility

Primary outcome measure(s)

• The immune function at 7 days after surgery — 7 days
  The level of the immune function(Complement C3; Complement C4; IgG; IgA; IgM;CD19;CD20;CD16;CD56;CD3;CD4) at 7 days after surgery.
• The immune function at 1 month after surgery — 1 month
  The level of the immune function(Complement C3; Complement C4; IgG; IgA; IgM;CD19;CD20;CD16;CD56;CD3;CD4) at 1 month after surgery.
• The immune function at 3 months after surgery — 3 months
  The level of the immune function(Complement C3; Complement C4; IgG; IgA; IgM;CD19;CD20;CD16;CD56;CD3;CD4) at 3 months after surgery.
• The immune function at 6 months after surgery — 6 months
  The level of the immune function(Complement C3; Complement C4; IgG; IgA; IgM;CD19;CD20;CD16;CD56;CD3;CD4) at 6 months after surgery.
• The immune function at 12months after surgery — 12months
  The level of the immune function(Complement C3; Complement C4; IgG; IgA; IgM;CD19;CD20;CD16;CD56;CD3;CD4) at 12months after surgery.
• Routine blood tests (Erythrocyte Count; Hemoglobins; Red Cell Distribution Width; White Blood Cell Count; Neutrophils; Lymphocytes; Monocytes; Eosinophils; Basophils; Platelet Count; Mean Platelet Volume; Blood Platelet) at 1 month postoperatively. — 1 month
  1 month
• Routine blood tests (Erythrocyte Count; Hemoglobins; Red Cell Distribution Width; White Blood Cell Count; Neutrophils; Lymphocytes; Monocytes; Eosinophils; Basophils; Platelet Count; Mean Platelet Volume; Blood Platelet) at 3 months postoperatively. — 3 months
  3 months
• Routine blood tests (Erythrocyte Count; Hemoglobins; Red Cell Distribution Width; White Blood Cell Count; Neutrophils; Lymphocytes; Monocytes; Eosinophils; Basophils; Platelet Count; Mean Platelet Volume; Blood Platelet) at 6 months postoperatively. — 6 months
  6 months
• Routine blood tests (Erythrocyte Count; Hemoglobins; Red Cell Distribution Width; White Blood Cell Count; Neutrophils; Lymphocytes; Monocytes; Eosinophils; Basophils; Platelet Count; Mean Platelet Volume; Blood Platelet) at 12 months postoperatively. — 12 months
  12 months
• Hemodynamics (Vascular Diameter; Blood Flow Velocity) of the splenic vein,proper hepatic artery,and portal vein at 1 month postoperatively. — 1 month
  1 month
• Hemodynamics (Vascular Diameter; Blood Flow Velocity) of the splenic vein,proper hepatic artery,and portal vein at 3 months postoperatively. — 3 months
  3 months
• Hemodynamics (Vascular Diameter; Blood Flow Velocity) of the splenic vein,proper hepatic artery,and portal vein at 6 months postoperatively. — 6 months
  6 months
• Hemodynamics (Vascular Diameter; Blood Flow Velocity) of the splenic vein,proper hepatic artery,and portal vein at 12 months postoperatively. — 12 months
  12 months
• Thrombosis in the Portal Venous System. — 1 month
  1 month
• Thrombosis in the Portal Venous System. — 3 months
  3 months
• Thrombosis in the Portal Venous System. — 6 months
  6 months
• Thrombosis in the Portal Venous System. — 12 months
  12 months

Trial sites (1)

More Northern Jiangsu People's Hospital trials in China

Other trials for the same condition